News & Views

  • Research to Assess Gene Therapies Delivery

Research to Assess Gene Therapies Delivery

Nov 01 2017 Read 583 Times

A research collaboration is to assess the effectiveness of developing gene therapies using Avacta Group’s Affimer technology combined with FIT Biotech Oy’s gtGTU® platform. The very small, simply structured Affirmer proteins have ideal potential for delivering the DNA blueprint of therapeutic proteins into patient’s cells where it can be reproduced, although this natural process does need to achieve clinically relevant levels of the protein drug to be effective.

FIT Biotech’s gtGTU, a vector for delivering genes to patients, was developed to ensure the stable and prolonged production of therapeutic proteins by the patient’s cells, in a safe manner. It removes the requirement for frequent administration of biological therapeutics which are cleared from the body after a limited time.

Dr Alastair Smith, Avacta Group Chief Executive Officer said: “I am delighted that we are starting this collaboration with FIT Biotech. It is a very exciting prospect and the Group is keen to see the initial data from the pilot study which we anticipate will be in the first half of 2018.”

James Kuo, Chief Executive Officer of FIT Biotech added: “We very much look forward to working on this project together with Avacta (which) offers an exciting opportunity to take targeted therapies to a new level. This collaboration follows our strategy of bringing gtGTU to the gene therapy market through strong partnerships.”

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.


Digital Edition

Lab Asia December 2018

December 2018

In This Edition Articles - Determination of heroin in street drug samples with printable surface enhanced Raman scattering (P-SERS) - Advances in Protein Sample Preparation: Centrifugation i...

View all digital editions

Events

Smart Factory Expo (SFE 2019)

Jan 16 2019 Tokyo, Japan

Arab Health

Jan 28 2019 Dubai International Convention & Exhibition Centre

Nano Tech 2019

Jan 30 2019 Tokyo, Japan

World Congress on Chromatography

Jan 31 2019 Paris, France

SLAS 2019

Feb 02 2019 Washington, DC, USA.

View all events